arrow
Y

Yishan Ye

Sorbonne Universite
H指数:15
被引数:959

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Peri-transplant TP53 molecular MRD as a prognostic biomarker of relapse in TP53-mutated AML/MDS undergoing allogeneic HCT

移植前后TP53分子微小残留病作为TP53突变AML/MDS接受异基因造血干细胞移植患者复发的预后生物标志物

2026-06-260
OAAI
Small-molecule inhibition of YTHDC1 as a strategy against acute myeloid leukemia in mouse models

YTHDC1的小分子抑制作为小鼠模型中急性髓系白血病的策略

2026-02-040
PRE
TET2 mutation does not impact the prognosis of adult acute myeloid leukemia patients receiving a hematopoietic stem cell transplantation in first remission: similar outcome following matched sibling and unrelated versus haploidentical donor transplants in amulti-center retrospective analysis from the Global Committee and the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation

TET2突变不影响接受造血干细胞移植且处于首次缓解期的成人急性髓系白血病患者的预后:欧洲血液与骨髓移植学会全球委员会和急性白血病工作组的多中心回顾性分析显示,配型相合的同胞或无关供者移植与单倍型相合供者移植后的结果相似。

2025-12-010
OAAI
Impact of TP53 variants and germline mutations on allogeneic stem cell transplantation outcomes in acute myeloid leukemia and myelodysplastic neoplasms

TP53变异和胚系突变对急性髓系白血病和骨髓增生异常肿瘤异基因造血干细胞移植结局的影响

Leukemia
IF13.4
2025-07-140
PRE
Superior GVHD-Free, Relapse-Free Survival for Haploidentical Transplant With PTCy Than Matched Unrelated Donor for AML Patients Transplanted in Second Complete Remission: A Study From the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation

与接受匹配无关供者移植的急性髓系白血病(AML)患者相比,半相合移植联合PTCy方案在第二次完全缓解期移植时,具有更优的GVHD-free、复发生存率:欧洲血液与骨髓移植学会急性白血病工作组的研究

2025-07-120
PRE
Management of liver sinusoidal obstruction syndrome/veno-occlusive disease in adults: a 2025 perspective from an international expert group

成人肝窦阻塞综合征/静脉闭塞性疾病的管理:国际专家小组的2025年展望

2025-04-220
PRE
Better Outcome Following Younger Haploidentical Donor Versus Older Matched Unrelated Donor Transplant for Fit Patients With Acute Myeloid Leukemia Transplanted in First Remission: A Study From the Global Committee and the Acute Leukemia Working Party of the EBMT

年轻单倍体匹配供者移植相比老年匹配无关供者移植,在急性髓系白血病首次缓解期移植的适合患者中可获得更好的结局:EBMT全球委员会和急性白血病工作组的研究

2025-04-070
PRE
Adult patients with Philadelphia chromosome positive acute lymphoblastic leukemia undergoing allogeneic hematopoietic stem cell transplantation and tyrosine kinase inhibitors: development and validation of a clinical prediction model based on cytogenetics, IKZF1 deletions and minimal residual disease
2025-01-230
OAAI